Özen ÖZ GÜL,
Soner CANDER
Evaluation of sitagliptin therapy on the levels of fibroblast growth factor-19 (FGF19) in patients with Type 2 diabetes
Evaluation of sitagliptin therapy on the levels of fibroblast growth factor-19 (FGF19) in patients with Type 2 diabetes
Turkish Journal of Internal Medicine
2022-Supplement 1
34-40
Type 2 diabetes mellitus,
fibroblast growth factor-19,
sitagliptin,
hyperglycemia,
blood glucose
81
76